1.
Palmieri C, Bird E, Simcock R, eds. ABC of Cancer Care. Wiley-Blackwell; 2013.
2.
Carlo P. ABC of Cancer Care. 1st ed. John Wiley & Sons, Incorporated; 2013. https://ebookcentral.proquest.com/lib/suss/detail.action?docID=1207852
3.
Cabot, Richard CHarris, Nancy Lee, MDRosenberg, Eric S, MDShepard, Jo-Anne O, MDCort, Alice M, MD. Case 14-2013. The New England Journal of Medicine. 368(19):1827-1835. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1349803228/99B6F5EFE846490BPQ/39?accountid=9727
4.
Kaye P. Breaking Bad News: A 10 Step Approach. EPL; 1996.
5.
Jonathan Silverman, Suzanne Kurtz, and Juliet Draper. Skills for Communicating with Patients, 3rd Edition. 3rd ed. Chapman and Hall/CRC; 2016. https://ebookcentral.proquest.com/lib/ubrighton/detail.action?docID=4742673
6.
Silverman J, Kurtz SM, Draper J. Skills for Communicating with Patients. Third edition. Radcliffe Publishing; 2013.
7.
Kurtz SM, Silverman J, Draper J. Teaching and Learning Communication Skills in Medicine. 2nd ed. Radcliffe; 2005. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2175116780002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
8.
Adler DD, Riba MB, Eggly S. Breaking Bad News in the Breast Imaging Setting. Academic Radiology. 2009;16(2):130-135. doi:10.1016/j.acra.2008.08.006
9.
Fujimori M, Uchitomi Y. Preferences of Cancer Patients Regarding Communication of Bad News: A Systematic Literature Review. Japanese Journal of Clinical Oncology. 2009;39(4):201-216. doi:10.1093/jjco/hyn159
10.
Hanratty, BarbaraLowson, ElizabethHolmes, LouiseGrande, GunnJacoby, Ann. Breaking bad news sensitively: what is important to patients in their last year of life? BMJ Supportive & Palliative Care. 2:53-59. https://search.proquest.com/docview/1783997881/fulltext/D9074EB1CBE345A7PQ/1?accountid=9727
11.
Hamilton, W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. The British Journal of Cancer. 101(1). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790706/
12.
Alfred G. Knudson, Jr. Mutation and Cancer: Statistical Study of Retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971;68(4). https://www-jstor-org.sussex.idm.oclc.org/stable/60687?sid=primo
13.
Gawande A, Wellcome Collection. Being Mortal: Illness, Medicine and What Matters in the End. Profile Books; 2015.
14.
Being Mortal. Published 2014. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS51112977480002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&isFrbr=true&tab=default&lang=en_US
15.
Mukherjee S. The Emperor of All Maladies: A Biography of Cancer. Fourth Estate; 2011. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2189620360002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
16.
Clark S. A Guide to Cancer Genetics in Clinical Practice. TFM; 2009.
17.
Firth HV, Hurst JA, Hall JG. Oxford Desk Reference: Clinical Genetics. Oxford University Press; 2005.
18.
Gene Reviews via the NCBI website : National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/
19.
OMIM - Online Mendelian Inheritance in Man. https://omim.org/
20.
Sorace J, Aberle DR, Elimam D, Lawvere S, Tawfik O, Wallace WD. Integrating pathology and radiology disciplines: an emerging opportunity? BMC Medicine. 2012;10(1). doi:10.1186/1741-7015-10-100
21.
Royal College of Pathologists datasets for histopathology reporting on cancers. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
22.
Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000;100(1):57-70. doi:10.1016/S0092-8674(00)81683-9
23.
Husband JE, Reznek RH. Husband & Reznek’s Imaging in Oncology. 3rd ed. Informa Healthcare; 2010. http://www.vlebooks.com/vleweb/product/openreader?id=Brighton&isbn=9780415874984
24.
American Joint Committee on Cancer. AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 7th ed. Springer; 2010. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2188698760002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
25.
Grégoire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology. 2014;110(1):172-181. doi:10.1016/j.radonc.2013.10.010
26.
Li B, Li Q, Nie W, Liu S. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis. European Journal of Radiology. 2014;83(2):338-344. doi:10.1016/j.ejrad.2013.11.017
27.
Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls: American Journal of Roentgenology. American Journal of Roentgenology. https://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
28.
Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? 2012;47(1). https://contentstore.cla.co.uk/secure/link?id=0968f686-0873-e911-80cd-005056af4099
29.
Imaging for Staging and Response Assessment in Lymphoma : Radiology. http://pubs.rsna.org.ezproxy.brighton.ac.uk/doi/full/10.1148/radiol.2015142088
30.
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology. 2014;32(27):3059-3067. doi:10.1200/JCO.2013.54.8800
31.
Dimopoulos MA, Hillengass J, Usmani S, et al. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement. Journal of Clinical Oncology. 2015;33(6):657-664. doi:10.1200/JCO.2014.57.9961
32.
Dow-Mu Koh, Matthew Blackledge, Anwar R. Padhani et al. Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls. https://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
33.
Berland LL, Silverman SG, Gore RM, et al. Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology. 2010;7(10):754-773. doi:10.1016/j.jacr.2010.06.013
34.
Gore RM, Wenzke DR, Thakrar KH, Newmark GM, Mehta UK, Berlin JW. The incidental cystic pancreas mass: a practical approach. Cancer Imaging. 2012;12(2):414-421. doi:10.1102/1470-7330.2012.9054
35.
Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST : American Journal of Roentgenology. http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.11.7483
36.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer. 2009;45(2):228-247. doi:10.1016/j.ejca.2008.10.026
37.
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria : RadioGraphics. http://pubs.rsna.org/doi/full/10.1148/rg.335125214
38.
A Radiologist’s Guide to Treatment Response Criteria in Oncologic Imaging: Anatomic Imaging Biomarkers : American Journal of Roentgenology. http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.12.9862
39.
Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging. https://pubs.rsna.org/doi/10.1148/radiol.2492072183
40.
Vardy J, Engelhardt K, Cox K, et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. British Journal of Cancer. 2004;91(6):1045-1049. doi:10.1038/sj.bjc.6602082
41.
Mehanna, HishamWong, Wai-LupMcConkey, Christopher CRahman, Joy KRobinson, Max. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. The New England Journal of Medicine. 374(15):1444-1454. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1781205526/AECA702A9F2C499DPQ/4?accountid=9727
42.
Balaji Ganeshan. Quantifying tumour heterogeneity with CT. Cancer Imaging. 2013;13(1). doi:doi: 10.1102/1470-7330.2013.0015
43.
British Thyroid Association Guidelines. https://www.british-thyroid-association.org/current-bta-guidelines-and-statements
44.
British Thoracic Society Guidelines for the investigation and management of pulmonary nodules. https://www.brit-thoracic.org.uk/document-library/clinical-information/pulmonary-nodules/bts-guidelines-for-pulmonary-nodules/
45.
NICE Suspected cancer: recognition and referral | Guidance and guidelines. https://www.nice.org.uk/guidance/ng12?unlid=9874814692015129115552,5161700902016923910
46.
Fleissig, AnneJenkins, ValerieCatt, SusanFallowfield, Lesley. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncology. 7(11):935-943. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/200993543/B199001EC4DE4BBFPQ/31?accountid=9727
47.
Munro AJ. Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone? Clinical Oncology. 2015;27(12):728-731. doi:10.1016/j.clon.2015.08.008
48.
Jalil R, Ahmed M, Green JSA, Sevdalis N. Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: An interview study of the provider perspective. International Journal of Surgery. 2013;11(5):389-394. doi:10.1016/j.ijsu.2013.02.026
49.
Lamb B, Payne H, Vincent C, Sevdalis N, Green JSA. The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership? Journal of Evaluation in Clinical Practice. 2011;17(6):1200-1206. doi:10.1111/j.1365-2753.2010.01507.x
50.
NHS Cancer Action Team: Quality in Nursing: Excellence in Cancer Care: The contribution of the Clinical Nurse Specialist. https://www.macmillan.org.uk/documents/aboutus/commissioners/excellenceincancercarethecontributionoftheclinicalnursespecialist.pdf
51.
Clark D, Armstrong M, Allan A, Graham F, Carnon A, Isles C. Imminence of death among hospital inpatients: Prevalent cohort study. Palliative Medicine. 2014;28(6):474-479. doi:10.1177/0269216314526443
52.
Costantini M, Romoli V, Leo SD, et al. Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial. The Lancet. 2014;383(9913):226-237. doi:10.1016/S0140-6736(13)61725-0
53.
Campion, Edward WKelley, Amy SMorrison, R Sean. Palliative Care for the Seriously Ill. The New England Journal of Medicine. 373(8):747-755. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1705787576/C2817B3DB58F4ADCPQ/8?accountid=9727
54.
May P, Garrido MM, Cassel JB, et al. Prospective Cohort Study of Hospital Palliative Care Teams for Inpatients With Advanced Cancer: Earlier Consultation Is Associated With Larger Cost-Saving Effect. Journal of Clinical Oncology. 2015;33(25):2745-2752. doi:10.1200/JCO.2014.60.2334
55.
Temel, Jennifer S, MDGreer, Joseph A, PhDMuzikansky, Alona, MAGallagher, Emily R, RNAdmane, Sonal, MB, BS, MPH. Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 363(8):733-742. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/746045208/D2D08130C77249DFPQ/1?accountid=9727
56.
National Confidential Enquiry into Patient Outcome and Death. https://www.ncepod.org.uk/2008report3/Downloads/SACT_report.pdf
57.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine. 365(5):395-409. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/881546508/4102C883EC5E4D19PQ/3?accountid=9727
58.
Black, William CGareen, Ilana FSoneji, Samir SSicks, JoRean DKeeler, Emmett B. Cost-Effectiveness of CT Screening in the National Lung Screening Trial. The New England Journal of Medicine. 371(19):1793-1802. http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1621375459/F618EBF5604B46B2PQ/2?accountid=9727
59.
Jefford M, Rowland J, Grunfeld E, Richards M, Maher J, Glaser A. Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. British Journal of Cancer. 2013;108(1):14-20. doi:10.1038/bjc.2012.554
60.
Living with and Beyond Cancer. Taking Action to Improve Outcomes. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/181054/9333-TSO-2900664-NCSI_Report_FINAL.pdf
61.
DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Tenth edition. Wolters Kluwer; 2015.
62.
DeVita, Hellman, and Rosenberg’s Cancer : Principles & Practice of Oncology. 10th ed. Wolters Kluwer Health; 2014. https://ebookcentral.proquest.com/lib/suss/detail.action?docID=2035697
63.
Hoskin PJ. External Beam Therapy. Vol Radiotherapy in practice. 2nd ed. Oxford University Press; 2012.
64.
Hoskin PJ, Coyle C. Brachytherapy. Vol Radiotherapy in practice. 2nd ed. Oxford University Press; 2011.
65.
Hoskin PJ, Goh V. Imaging. Vol Radiotherapy in practice. Oxford University Press; 2009.
66.
Hoskin PJ. Radioisotope Therapy. Vol Radiotherapy in practice. Oxford University Press; 2007.
67.
Practical Radiotherapy Planning: Contouring Atlases. https://www.rtog.org/CoreLab/ContouringAtlases.aspx
68.
Arends J, Bodoky G, Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition. 2006;25(2):245-259. doi:10.1016/j.clnu.2006.01.020
69.
Burnet NG. Defining the tumour and target volumes for radiotherapy. Cancer Imaging. 2004;4(2):153-161. doi:10.1102/1470-7330.2004.0054
70.
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis. Spine. 2005;30(19):2186-2191. doi:10.1097/01.brs.0000180401.06919.a5
71.
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/cg32
72.
Metastatic spinal cord compression in adults | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/qs56
73.
Neutropenic sepsis: prevention and management in people with cancer | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/cg151
74.
NICE IPG79 (2004) Stent placement for vena caval obstruction. https://www.nice.org.uk/guidance/ipg79
75.
MDT Development. http://www.ncin.org.uk/cancer_type_and_topic_specific_work/multidisciplinary_teams/mdt_development
